BRPI0906879A2 - Compostos terapêuticos - Google Patents
Compostos terapêuticosInfo
- Publication number
- BRPI0906879A2 BRPI0906879A2 BRPI0906879-1A BRPI0906879A BRPI0906879A2 BR PI0906879 A2 BRPI0906879 A2 BR PI0906879A2 BR PI0906879 A BRPI0906879 A BR PI0906879A BR PI0906879 A2 BRPI0906879 A2 BR PI0906879A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic compounds
- therapeutic
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2228208P | 2008-01-18 | 2008-01-18 | |
| US12/352,995 US7964595B2 (en) | 2008-01-18 | 2009-01-13 | Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension |
| PCT/US2009/030895 WO2009091765A1 (en) | 2008-01-18 | 2009-01-14 | Therapeutic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0906879A2 true BRPI0906879A2 (pt) | 2015-07-07 |
Family
ID=40876973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0906879-1A BRPI0906879A2 (pt) | 2008-01-18 | 2009-01-14 | Compostos terapêuticos |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7964595B2 (enExample) |
| EP (1) | EP2240462B1 (enExample) |
| JP (1) | JP5393700B2 (enExample) |
| AU (1) | AU2009205478B2 (enExample) |
| BR (1) | BRPI0906879A2 (enExample) |
| CA (1) | CA2712192C (enExample) |
| DK (1) | DK2240462T3 (enExample) |
| ES (1) | ES2434963T3 (enExample) |
| WO (1) | WO2009091765A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102143753B (zh) * | 2008-09-04 | 2013-07-03 | 参天制药株式会社 | 含有15,15-二氟前列腺素F2α衍生物作为有效成分的毛发生长促进剂 |
| CA2874288A1 (en) * | 2012-05-30 | 2013-12-05 | Asahi Glass Company, Limited | Composition for hair growth |
| US9540357B1 (en) | 2014-07-31 | 2017-01-10 | Allergan, Inc. | 15-aryl prostaglandins as EP4 agonists, and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4543353A (en) * | 1981-11-27 | 1985-09-24 | Farmitalia Carlo Erba S.P.A. | Ester and amide derivatives of 13,14-didehydro prostaglandins |
| JPH0692305B2 (ja) * | 1987-05-15 | 1994-11-16 | 株式会社上野製薬応用研究所 | 体温上昇剤 |
| US5688819A (en) | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| CZ20013174A3 (cs) * | 1999-03-05 | 2002-02-13 | The Procter & Gamble Company | C16 nenasycené FP-selektivní prostaglandinové analogy |
| WO2000051977A1 (en) * | 1999-03-05 | 2000-09-08 | The Procter & Gamble Company | Aldehyde intermediates for the preparation of prostaglandin derivatives |
| IL143477A (en) | 2001-05-31 | 2009-07-20 | Finetech Pharmaceutical Ltd | Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives |
| US7166730B2 (en) * | 2000-01-27 | 2007-01-23 | Fine Tech Laboratories, Ltd | Process for the preparation of prostaglandin derivatives |
| US7101904B2 (en) * | 2004-08-10 | 2006-09-05 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US7427685B2 (en) * | 2005-12-06 | 2008-09-23 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
| US20070254920A1 (en) * | 2006-04-26 | 2007-11-01 | Aerie Pharmaceuticals, Inc. | Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
-
2009
- 2009-01-13 US US12/352,995 patent/US7964595B2/en active Active
- 2009-01-14 WO PCT/US2009/030895 patent/WO2009091765A1/en not_active Ceased
- 2009-01-14 JP JP2010543201A patent/JP5393700B2/ja not_active Expired - Fee Related
- 2009-01-14 DK DK09702525.8T patent/DK2240462T3/da active
- 2009-01-14 CA CA2712192A patent/CA2712192C/en not_active Expired - Fee Related
- 2009-01-14 EP EP09702525.8A patent/EP2240462B1/en not_active Not-in-force
- 2009-01-14 ES ES09702525T patent/ES2434963T3/es active Active
- 2009-01-14 BR BRPI0906879-1A patent/BRPI0906879A2/pt not_active IP Right Cessation
- 2009-01-14 AU AU2009205478A patent/AU2009205478B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009091765A1 (en) | 2009-07-23 |
| AU2009205478B2 (en) | 2014-01-16 |
| EP2240462B1 (en) | 2013-08-21 |
| JP5393700B2 (ja) | 2014-01-22 |
| AU2009205478A1 (en) | 2009-07-23 |
| JP2011522775A (ja) | 2011-08-04 |
| EP2240462A1 (en) | 2010-10-20 |
| ES2434963T3 (es) | 2013-12-18 |
| CA2712192A1 (en) | 2009-07-23 |
| CA2712192C (en) | 2016-06-14 |
| US7964595B2 (en) | 2011-06-21 |
| DK2240462T3 (da) | 2013-10-28 |
| US20090186885A1 (en) | 2009-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0916931A2 (pt) | agentes terapêuticos | |
| DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
| EP2320907A4 (en) | THERAPEUTIC COMPOUNDS | |
| BRPI0920707A2 (pt) | compostos | |
| DK2242759T3 (da) | Forbindelser | |
| EP2296593A4 (en) | MEDICAL HEAD COVER | |
| BRPI0813500A2 (pt) | Compostos antivirais | |
| BRPI0821086A2 (pt) | Compostos inseticidas | |
| EP2268285A4 (en) | THERAPEUTIC COMPOUNDS | |
| SMT201600045B (it) | Composti tetraciclinici c7-fluoro sostituiti | |
| BRPI0811264A2 (pt) | Compostos | |
| DK2297162T3 (da) | Forbindelser | |
| BRPI0809996A2 (pt) | Compostos | |
| BRPI0814424A2 (pt) | Compostos heterociclila | |
| BRPI0916432A2 (pt) | compostos | |
| BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
| DK2271618T3 (da) | Farmaceutiske forbindelser | |
| BRPI0815181A2 (pt) | Compostos | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| EP2427183A4 (en) | THERAPEUTIC COMPOUNDS | |
| DK2206698T3 (da) | Ethynylindolforbindelser | |
| HRP20160577T1 (hr) | Liječenje osteoartritisa | |
| BRPI0910931A2 (pt) | ciclopentanos substituídos terapêuticos | |
| PL3825306T3 (pl) | Związki morfinanu | |
| BRPI0922152A2 (pt) | Compostos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2342 DE 24-11-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |